Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Equity
$165.73
+$2.35 · +1.44%
· Aug 21, 4:00 PM ET
$166.19
+$0.46 · +0.28%
· Aug 24, 4:06 AM ET
$165.73
Previous close+$2.35 · +1.44%
· Aug 21, 4:00 PM ET
$166.19
+$0.46 · +0.28%
· Aug 24, 4:06 AM ET
$165.71
+$2.33 · +1.43%
Regular session · ET · Market data may be delayed.
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Fund assets
11.39B USD
Expense ratio
0.35%
NAV
$163.31
Average volume
8.72M
Volume
9.96M
Day range
$163.65 – $167.91
52-week range
$88.60 – $169.68
Previous close
$163.38
Price change
1 day
+1.44%
1 month
+10.13%
3 months
+25.88%
Year to date
+35.92%
1 year
+86.65%
3 years
+112.97%
5 years
+29.73%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
